1.
Vopr Onkol
; 53(1): 21-5, 2007.
Article
in Russian
| MEDLINE
| ID: mdl-17649729
ABSTRACT
The efficacy of primary chemotherapy for inflammatory breast carcinoma (IBC) was studied vis-a-vis certain symptoms characterizing patient's status and biological features of tumor. It was shown that such factors as estrogen (ER) and progesterone (PR) receptor status and malignancy grade of tumor can be used to predict the efficacy. Negative ER/PR status plus high malignancy grade involved higher frequency of complete pathomorphological responses. Worst prognosis was in patients under 35 years of age, with ductal BC and negative ER/PR status of tumor.
Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Carcinoma/drug therapy , Carcinoma/pathology , Adult , Biomarkers, Tumor/analysis , Breast Neoplasms/mortality , Humans , Inflammation/drug therapy , Inflammation/pathology , Prognosis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Survival Analysis , Treatment Outcome
2.
Vopr Onkol
; 50(6): 729-36, 2004.
Article
in Russian
| MEDLINE
| ID: mdl-15755074
Subject(s)
Androstadienes/therapeutic use , Antineoplastic Agents/therapeutic use , Aromatase Inhibitors/therapeutic use , Breast Neoplasms/drug therapy , Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Chemotherapy, Adjuvant , Female , Humans , Tamoxifen/therapeutic use , Treatment Outcome
3.
Vopr Onkol
; 48(1): 106-9, 2002.
Article
in Russian
| MEDLINE
| ID: mdl-12101557
